Search

Author/Creator Andrea, Fülöp

1. A phase III, randomized, double-blind, multicenter study to compare the efficacy, safety, pharmacokinetics, and immunogenicity between SB8 (proposed bevacizumab biosimilar) and reference bevacizumab in patients with metastatic or recurrent nonsquamous non-small cell lung cancer. (August 2020)

Authors:
Reck, Martin; Luft, Alexander; Bondarenko, Igor; Shevnia, Serhii; Trukhin, Dmytro; Kovalenko, Nadezhda V.; Vacharadze, Kakha; Andrea, Fülöp; Hontsa, Anatoliy; Choi, Jihye; Shin, Donghoon
Journal:
Lung cancer
Issue:
Volume 146(2020)
Page Start:
12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search